E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/21/2016 in the Prospect News Structured Products Daily.

New Issue: RBC prices $2.3 million contingent coupon autocallables on two stocks

By Marisa Wong

Morgantown, W.Va., June 21 – Royal Bank of Canada priced $2.3 million of autocallable contingent coupon barrier notes due Dec. 21, 2016 linked to the worse performing of two stocks, Celgene Corp. and Microsoft Corp., according to a 424B2 filing with the Securities and Exchange Commission.

Each quarter, the notes will pay a contingent coupon of 11.57% per year if each stock closes at or above its coupon barrier level, 75% of its initial price, on the observation date for that quarter.

The notes will be called at par if each stock closes at or above its initial price on any quarterly observation date.

If the notes are not called and each stock finishes at or above its 75% trigger level, the payout at maturity will be par plus the final contingent coupon. Otherwise, investors will receive a number of shares of the worse performing stock equal to $1,000 divided by the initial share price or, at the issuer’s option, the cash value of those shares.

RBC Capital Markets, LLC is the agent.

Issuer:Royal Bank of Canada
Issue:Autocallable contingent coupon barrier notes
Underlying stocks:Celgene Corp. (Symbol: CELG), Microsoft Corp. (Symbol: MSFT)
Amount:$2.3 million
Maturity:Dec. 21, 2016
Coupon:11.57% per year, payable quarterly if each stock closes at or above coupon barrier on observation date for that quarter
Price:Par
Payout at maturity:If each stock finishes at or above its trigger level, par plus the final contingent coupon; otherwise, a number of shares of the worse performing stock equal to $1,000 divided by the initial share price or, at the issuer’s option, the cash value of those shares
Call:Automatically at par if each stock closes at or above initial price on any quarterly observation date
Initial prices:$100.23 for Celgene, $50.39 for Microsoft
Trigger/coupon barrier:$75.17 for Celgene and $37.79 for Microsoft; 75% of initial prices
Pricing date:June 16
Settlement date:June 21
Agent:RBC Capital Markets LLC
Fees:1.75%
Cusip:78013GBC8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.